Glassman Wealth Services’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Glassman Wealth Services’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-96	Closed	-$1.55K	–	1952
2023 Q4	$1.55K	Hold	96	–	–	﹤0.01%	1419
2023 Q3	$1.22K	Hold	96	–	–	﹤0.01%	1493
2023 Q2	$1.35K	Hold	96	–	–	﹤0.01%	1360
2023 Q1	$1.48K	Hold	96	–	–	﹤0.01%	1328
2022 Q4	$1.57K	Hold	96	–	–	﹤0.01%	1313
2022 Q3	$2K	Hold	96	–	–	﹤0.01%	1292
2022 Q2	$1K	Buy	96 +34	+55%	+$375	﹤0.01%	1597
2022 Q1	$1K	Buy	+62	New	+$527	﹤0.01%	1579

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Glassman Wealth Services's DCPH Position: Q1 2024 in Review

Glassman Wealth Services sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 96 shares — an estimated $1.55K sold.

Glassman Wealth Services first reported a position in DCPH in Q1 2022 and held it in 8 quarters. The position peaked at $2K in Q3 2022. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

Glassman Wealth Services reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 96 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $1.55K.
Glassman Wealth Services first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
Glassman Wealth Services's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q3 2022.
177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.